Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Paroxetine Hydrochloride Push-pull Osmotic Pump Tablets: Designing an Innovative, Scalable Push-pull Osmotic Drug Delivery System Using QbD Approach

Author(s): Prathmesh P. Kenjale, Manjusha A. Joshi, Umesh N. Khatavkar, Vividha V. Dhapte and Varsha B. Pokharkar*

Volume 10, Issue 2, 2020

Page: [104 - 116] Pages: 13

DOI: 10.2174/2210303109666190902112941

Price: $65

Abstract

Background: Paroxetine hydrochloride hemihydrate (PHH) is a serotonin reuptake inhibitor useful for the treatment of diverse psychiatric problems. Existing marketed formulations with frequent administration lead to gastrointestinal (GI) reactions and abrupt fluctuations in plasma level with poor patient compliance. These prerequisites are sufficed by controlled release push-pull osmotic pump tablets (PPOP).

Objective: Objective of the present study was to develop robust and reliable PPOP formulation via Quality by design (QbD) approach to achieve desired release kinetics.

Methods: PPOP was formulated using wet granulation method followed by osmotic coating. QbD strategy for defining the risk assessment of influential variables such as swelling polymers and osmogen on in vitro release kinetics of designed PPOP.

Results: Presence of Polyox in push and pull layer along with osmogen controlled the drug release pattern from formulated PPOP system as depicted in 33 factorial design. These formulated optimized PPOP systems demonstrated 2 hrs lag time with zero-order kinetics, a peculiar feature of PPOPs.

Conclusion: Scalable, stable PPOP tablets were fabricated by applying systematic QbD approach. The developed PPOP systems with improved concentration-independent behavior helped to address the challenges of existing marketed formulations. Risk mitigation and control strategy assured quality of the system during scalability. Application of QbD strategy in establishing the PPOP formulation would help in formulating drug candidates having gastric limitations and poor patient compliance. The present study is the detailed account of QbD based PPOP formulation, therefore it can be of potential importance from academics as well as industrial perspective.

Keywords: Push-pull osmotic pump, factorial design, polyox, osmogen, tablet, QbD.

Next »
Graphical Abstract

[1]
Zanardi, R.; Colombo, L.; Marcheggiani, E.; Rossini, D.; Delmonte, D.; Cigala Fulgosi, M.; Gavinelli, C.; Colombo, C. Paroxetine drops versus paroxetine tablets: evaluation of compliance in a six-month study. Riv. Psichiatr., 2013, 48(3), 261-267.
[PMID: 23752809]
[2]
Higuchi, T.; Hong, J.P.; Jung, H.Y.; Watanabe, Y.; Kunitomi, T.; Kamijima, K. Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea. Psychiatry Clin. Neurosci., 2011, 65(7), 655-663.
[http://dx.doi.org/10.1111/j.1440-1819.2011.02243.x] [PMID: 21895859]
[3]
Jin, S.J.; Yoo, Y.H.; Kim, M.S.; Kim, J.S.; Park, J.S.; Hwang, S.J. Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design. Arch. Pharm. Res., 2008, 31(3), 399-405.
[http://dx.doi.org/10.1007/s12272-001-1170-0] [PMID: 18409056]
[4]
Pandey, Y.R.; Kumar, S.; Gupta, B.K.; Ali, J.; Baboota, S. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology, 2016, 27(2)025102
[http://dx.doi.org/10.1088/0957-4484/27/2/025102] [PMID: 26629830]
[5]
El-Nabarawi, M.A.; Bendas, E.R.; El Rehem, R.T.; Abary, M.Y. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int. J. Pharm., 2013, 443(1-2), 307-317.
[http://dx.doi.org/10.1016/j.ijpharm.2013.01.016] [PMID: 23337629]
[6]
United States Food and Drug Administration. 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020936s035lbl.pdf
[7]
Thirumaran, M.; Balakumar, K.; Raghavan, CV.; Thuvaragan, S. Formulation and in vitro release kinetic study of an enteric coated paroxetine controlled release tablets. Asian journal of research in chemistry and pharmaceutical sciences., 2014, 2(2), 63-73.
[8]
United States Pharmacopoeia. United States Pharmacopeia and National Formulary (USP 40- NF 35), 39th ed; The United States Pharmacopeial Convention: Rockville, MD, 2018.
[9]
Phaechamud, T.; Darunkaisorn, W. Drug release behavior of polymeric matrix filled in capsule. Saudi Pharm. J., 2016, 24(6), 627-634.
[http://dx.doi.org/10.1016/j.jsps.2015.04.003] [PMID: 27829804]
[10]
Malaterre, V.; Ogorka, J.; Loggia, N.; Gurny, R. Oral osmotically driven systems: 30 years of development and clinical use. Eur. J. Pharm. Biopharm., 2009, 73(3), 311-323.
[http://dx.doi.org/10.1016/j.ejpb.2009.07.002] [PMID: 19602438]
[11]
Patel, V.; Chudasama, A.; Nivsarkar, M.; Vasu, K.; Shishoo, C. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization. Pharm. Dev. Technol., 2012, 17(3), 375-382.
[http://dx.doi.org/10.3109/10837450.2010.542577] [PMID: 21284541]
[12]
Malaterre, V.; Pedersen, M.; Ogorka, J.; Gurny, R.; Loggia, N.; Taday, P.F. Terahertz pulsed imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems. Eur. J. Pharm. Biopharm., 2010, 74(1), 21-25.
[http://dx.doi.org/10.1016/j.ejpb.2008.10.011] [PMID: 19013522]
[13]
Qin, C.; He, W.; Zhu, C.; Wu, M.; Jin, Z.; Zhang, Q.; Wang, G.; Yin, L. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int. J. Pharm., 2014, 466(1-2), 276-285.
[http://dx.doi.org/10.1016/j.ijpharm.2014.03.002] [PMID: 24607209]
[14]
Zhao, Z.; Wu, C.; Zhao, Y.; Hao, Y.; Liu, Y.; Zhao, W. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles. Int. J. Nanomedicine, 2015, 10, 1691-1701.
[PMID: 25784799]
[15]
Sangshetti, J.; Deshpande, M.; Zaheer, Z.; Shinde, D.; Arote, R. Quality by design approach: Regulatory need. Arab. J. Chem., 2017, 10, 3412-3425.
[http://dx.doi.org/10.1016/j.arabjc.2014.01.025]
[16]
Zhang, L.; Mao, S. Application of quality by design in the current drug development. Asian J Pharm, 2017, 12, 1-8.
[http://dx.doi.org/10.1016/j.ajps.2016.07.006]
[17]
Lee, A.R.; Kwon, S.Y.; Choi, D.H.; Park, E.S. Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo®) manufactured via high shear wet granulation. Int. J. Pharm., 2017, 534(1-2), 144-158.
[http://dx.doi.org/10.1016/j.ijpharm.2017.10.004] [PMID: 29031980]
[18]
Mehta, P.; Dhapte, V. Propulsive PAT paradigm: Optimization of Freeze Drying Process. Int. J. Pharm. Sci. Rev. Res., 2014, 28, 240-246.
[19]
Prabakaran, D.; Singh, P.; Kanaujia, P.; Jaganathan, K.S.; Rawat, A.; Vyas, S.P. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int. J. Pharm., 2004, 284(1-2), 95-108.
[http://dx.doi.org/10.1016/j.ijpharm.2004.07.015] [PMID: 15454301]
[20]
Liu, L.; Ku, J.; Khang, G.; Lee, B.; Rhee, J.M.; Lee, H.B. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control. Release, 2000, 68(2), 145-156.
[http://dx.doi.org/10.1016/S0168-3659(00)00243-1] [PMID: 10925123]
[21]
Zhang, Z.H.; Dong, H.Y.; Peng, B.; Liu, H.F.; Li, C.L.; Liang, M.; Pan, W.S. Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs. Int. J. Pharm., 2011, 410(1-2), 41-47.
[http://dx.doi.org/10.1016/j.ijpharm.2011.03.013] [PMID: 21419199]
[22]
United States Food and Drug Administration. Quality by Design for ANDAs: An Example for Modified Release Dosage Forms, 2011.
[23]
Iurian, S.; Turdean, L.; Tomuta, I. Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone. Drug Des. Devel. Ther., 2017, 11, 733-746.
[http://dx.doi.org/10.2147/DDDT.S125323] [PMID: 28331293]
[24]
Boldhane, S.P.; Kuchekar, B.S. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design. Curr. Drug Deliv., 2009, 6(5), 477-485.
[http://dx.doi.org/10.2174/156720109789941641] [PMID: 19863493]
[25]
Yadav, K.S.; Sawant, K.K. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr. Drug Deliv., 2010, 7(1), 51-64.
[http://dx.doi.org/10.2174/156720110790396517] [PMID: 20044908]
[26]
Dhapte, V.; Pokharkar, V. Polyelectrolyte stabilized antimalarial nanosuspension using factorial design approach. J. Biomed. Nanotechnol., 2011, 7(1), 139-141.
[http://dx.doi.org/10.1166/jbn.2011.1239] [PMID: 21485841]
[27]
Brittain, H.G. Profiles of Drug Substances, Excipients and Related Methodology, 1st ed; Elsevier: UK, 2013.
[28]
Pobudkowska, A.; Domańska, U. Study of pH-dependent drugs solubility in water. Chem. Ind. Chem. Eng. Q., 2014, 20, 115-126.
[http://dx.doi.org/10.2298/CICEQ120531116P]
[29]
Theeuwes, F. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. US Patent, 1978.
[30]
Missaghi, S.; Patel, P.; Farrell, T.P.; Huatan, H.; Rajabi-Siahboomi, A.R. Investigation of critical core formulation and process parameters for osmotic pump oral drug delivery. AAPS PharmSciTech, 2014, 15(1), 149-160.
[http://dx.doi.org/10.1208/s12249-013-0040-4] [PMID: 24222269]
[31]
Malaterre, V.; Ogorka, J.; Loggia, N.; Gurny, R. Approach to design push-pull osmotic pumps. Int. J. Pharm., 2009, 376(1-2), 56-62.
[http://dx.doi.org/10.1016/j.ijpharm.2009.04.015] [PMID: 19383532]
[32]
Li, W.; Du, G.; Yang, X.; Zhang, Z.; Nie, S.; Peng, B.; Pan, W. In vitro and in vivo evaluation of a novel push-pull osmotic pump with orifices on both side surfaces. Drug Dev. Ind. Pharm., 2008, 34(12), 1350-1355.
[http://dx.doi.org/10.1080/10673220802122928] [PMID: 18850364]
[33]
Deng, H.; Martin, L.; Missaghi, S.; Farrell, T.; Rajabi-Siahboomi, A. Applications of Opadry® CA, a fully formulated cellulose acetate based coating system for osmotic pump tablets; Poster Reprint AAPS, 2012.
[34]
Khairnar, G.; Naik, J.; Mokale, V. A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium by 32 factorial design approach. Bull. Fac. Pharm. Cairo Univ., 2017, 55, 19-29.
[http://dx.doi.org/10.1016/j.bfopcu.2016.10.001]
[35]
Nayak, A.K.; Pal, D.; Pradhan, J.; Hasnain, M.S. Fenugreek seed mucilage-alginate mucoadhesive beads of metformin HCl: Design, optimization and evaluation. Int. J. Biol. Macromol., 2013, 54, 144-154.
[http://dx.doi.org/10.1016/j.ijbiomac.2012.12.008] [PMID: 23246901]
[36]
Sahoo, C.; Sahoo, N.; Rao, S.; Sudhakar, M.; Satyanarayana, K. A review on controlled porosity osmotic pump tablets and its evaluation. Bull. Fac. Pharm. Cairo Univ., 2014, 53, 195-205.
[http://dx.doi.org/10.1016/j.bfopcu.2015.10.004]
[37]
Wu, C.; Zhao, Z.; Zhao, Y.; Hao, Y.; Liu, Y.; Liu, C. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure. Int. J. Pharm., 2014, 475(1-2), 298-305.
[http://dx.doi.org/10.1016/j.ijpharm.2014.08.033] [PMID: 25148731]
[38]
Xin, T.; Zhao, Y.; Jing, H.; Zhang, W.; Gao, Y.; Yang, X.; Qu, X.; Pan, W. A time-released osmotic pump fabricated by compression-coated method: Formulation screen, mechanism research and pharmacokinetic study. Asian J. Pharm., 2014, 9, 208-217.
[http://dx.doi.org/10.1016/j.ajps.2014.05.003]
[39]
Waterman, K.C.; Goeken, G.S.; Konagurthu, S.; Likar, M.D.; MacDonald, B.C.; Mahajan, N.; Swaminathan, V. Osmotic capsules: A universal oral, controlled-release drug delivery dosage form. J. Control. Release, 2011, 152(2), 264-269.
[http://dx.doi.org/10.1016/j.jconrel.2011.02.001] [PMID: 21315121]
[40]
Shrivastava, A.R.; Ursekar, B.; Kapadia, C.J. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets. Curr. Drug Deliv., 2009, 6(1), 28-37.
[http://dx.doi.org/10.2174/156720109787048258] [PMID: 19418953]
[41]
Patel, A.; Dodiya, H.; Shelate, P.; Shastri, D.; Dave, D. Design, Characterization, and Optimization of Controlled Drug Delivery System Containing Antibiotic Drug/s. J. Drug Deliv., 2016, 20169024173
[http://dx.doi.org/10.1155/2016/9024173] [PMID: 27610247]
[42]
Jain, D.; Darwhekar, G.; Solanki, S.; Sharma, R. Osmotically regulated asymmetric capsular system for sustained delivery of indomethacin. J. Pharm. Investig., 2013, 43, 27-35.
[http://dx.doi.org/10.1007/s40005-012-0050-3]
[43]
Ketjinda, W.; Sinchaipanid, N.; Limsuwan, P.; Leuenberger, H.; Mitrevej, A. Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer. AAPS PharmSciTech, 2011, 12(1), 132-140.
[http://dx.doi.org/10.1208/s12249-010-9572-z] [PMID: 21181509]

Rights & Permissions Print Cite
Article Metrics
14
© 2024 Bentham Science Publishers | Privacy Policy